BriaCell Therapeutics's total assets for Q2 2025 were $9.36M, a decrease of -10.09% from the previous quarter. TSE:BCT total liabilities were $6.14M for the fiscal quarter, a -8.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.